Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014004
Filing Date
2024-10-31
Accepted
2024-10-31 07:20:13
Documents
84
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20240930x10q.htm   iXBRL 10-Q 2796781
2 EX-31.1 bcyc-20240930xex31d1.htm EX-31.1 14213
3 EX-31.2 bcyc-20240930xex31d2.htm EX-31.2 14403
4 EX-32.1 bcyc-20240930xex32d1.htm EX-32.1 10549
  Complete submission text file 0001558370-24-014004.txt   10846132

Data Files

Seq Description Document Type Size
5 EX-101.SCH bcyc-20240930.xsd EX-101.SCH 87232
6 EX-101.CAL bcyc-20240930_cal.xml EX-101.CAL 57293
7 EX-101.DEF bcyc-20240930_def.xml EX-101.DEF 358991
8 EX-101.LAB bcyc-20240930_lab.xml EX-101.LAB 643471
9 EX-101.PRE bcyc-20240930_pre.xml EX-101.PRE 523987
87 EXTRACTED XBRL INSTANCE DOCUMENT bcyc-20240930x10q_htm.xml XML 1749483
Mailing Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS
Business Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS 011441223261503
BICYCLE THERAPEUTICS PLC (Filer) CIK: 0001761612 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 241412423
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)